Credit Suisse’s Harte-Hanks HHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$898K Sell
120,000
-6,872
-5% -$52.3K ﹤0.01% 2325
2023
Q4
$861K Hold
126,872
﹤0.01% 2431
2023
Q3
$827K Hold
126,872
﹤0.01% 2402
2023
Q2
$695K Sell
126,872
-1,750
-1% -$11.9K ﹤0.01% 2614
2023
Q1
$1.21M Hold
128,622
﹤0.01% 2211
2022
Q4
$1.5M Hold
128,622
﹤0.01% 2050
2022
Q3
$1.43M Hold
128,622
﹤0.01% 2067
2022
Q2
$1.64M Sell
128,622
-231
-0.2% -$2.02K ﹤0.01% 2047
2022
Q1
$975K Hold
128,853
﹤0.01% 2570
2021
Q4
$980K Buy
+128,853
New +$1.02M ﹤0.01% 3334
2020
Q3
Sell
-129,208
Closed -$393K 4064
2020
Q2
$393K Sell
129,208
-900
-0.7% -$2.13K ﹤0.01% 3455
2020
Q1
$204K Sell
130,108
-12,378
-9% -$36.8K ﹤0.01% 3641
2019
Q4
$510K Buy
142,486
+12,200
+9% +$36.3K ﹤0.01% 3556
2019
Q3
$397K Sell
130,286
-36
-0% -$113 ﹤0.01% 3564
2019
Q2
$287K Sell
130,322
-79
-0.1% -$251 ﹤0.01% 3700
2019
Q1
$466K Buy
130,401
+593
+0.5% +$2.06K ﹤0.01% 3371
2018
Q4
$314K Sell
129,808
-100
-0.1% -$477 ﹤0.01% 3493
2018
Q3
$926K Buy
129,908
+106
+0.1% +$932 ﹤0.01% 2927
2018
Q2
$1.44M Sell
129,802
-1,908
-1% -$19.5K ﹤0.01% 2733
2018
Q1
$1.21M Buy
131,710
+10
+0% +$92 ﹤0.01% 2827
2017
Q4
$1.25M Sell
131,700
-9
-0% -$91 ﹤0.01% 2830
2017
Q3
$1.41M Sell
131,709
-1,001
-0.8% -$9.21K ﹤0.01% 2848
2017
Q2
$1.37M Sell
132,710
-97
-0.1% -$1.22K ﹤0.01% 2487
2017
Q1
$1.86M Sell
132,807
-268
-0.2% -$4.08K ﹤0.01% 2394
2016
Q4
$2.01M Sell
133,075
-946
-0.7% -$14.3K ﹤0.01% 2437
2016
Q3
$2.17M Sell
134,021
-7,307
-5% -$120K ﹤0.01% 2312
2016
Q2
$2.25M Buy
141,328
+6,749
+5% +$119K ﹤0.01% 2246
2016
Q1
$3.4M Buy
134,579
+11,352
+9% +$349K ﹤0.01% 1794
2015
Q4
$3.99M Sell
123,227
-13,424
-10% -$503K ﹤0.01% 1761
2015
Q3
$4.82M Buy
136,651
+14,538
+12% +$656K 0.01% 1597
2015
Q2
$7.28M Sell
122,113
-1,544
-1% -$104K 0.01% 1456
2015
Q1
$9.65M Sell
123,657
-29,754
-19% -$2.3M 0.01% 1219
2014
Q4
$11.9M Sell
153,411
-29,149
-16% -$1.91M 0.01% 1167
2014
Q3
$11.6M Sell
182,560
-612
-0.3% -$41.6K 0.01% 1208
2014
Q2
$13.2M Buy
183,172
+6,819
+4% +$526K 0.01% 1209
2014
Q1
$15.6M Buy
176,353
+7,868
+5% +$612K 0.02% 964
2013
Q4
$13.2M Buy
168,485
+13,126
+8% +$1.07M 0.01% 1066
2013
Q3
$13.7M Buy
155,359
+1,393
+0.9% +$127K 0.01% 953
2013
Q2
$13.2M Buy
+153,966
New +$12.7M 0.01% 984

Other funds holding HHS

Credit Suisse's HHS Position: Q1 2024 in Review

Credit Suisse reduced its Harte-Hanks (HHS) stake by 5.4% in Q1 2024, selling an estimated $52.3K and leaving 120,000 shares worth $898K. The position accounts for ﹤0.01% of the portfolio, ranked #2325.

Credit Suisse first reported a position in HHS in Q2 2013 and has held it in 39 quarters since. The position peaked at $15.6M in Q1 2014. 27 funds tracked by Wall St. Rank hold HHS as of Q1 2024.

  • Credit Suisse held 120,000 shares of Harte-Hanks worth $898K as of Q1 2024.
  • Credit Suisse sold 6,872 Harte-Hanks shares in Q1 2024, an estimated $52.3K.
  • Harte-Hanks made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2325 holding.
  • Credit Suisse first reported a position in Harte-Hanks in Q2 2013 and has held it in 39 quarters since.
  • Credit Suisse's Harte-Hanks position peaked at $15.6M in Q1 2014.
  • 27 funds tracked by Wall St. Rank held Harte-Hanks as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.